Mounjaro Day 2: What to Expect After Your First Injection (October 2026)

01 · The core answer

What to expect on Mounjaro day 2

Expect a quiet, mild or uneventful day 2 on Mounjaro. Tirzepatide works by activating two gut-hormone receptors, GIP and GLP-1, which help regulate appetite and slow how quickly the stomach empties.¹ In practice, most people feel fuller sooner and less hungry between meals, but how quickly you notice that differs from person to person.

Side effects follow a pattern: they appear in the first days after starting or increasing a dose, peak early and settle as your body adapts.¹ So if you feel a bit queasy, bloated or tired today, that is within the expected range. If you feel nothing at all, that is also within the expected range. Neither tells you how well the medicine will work for you over the coming months.

Many people on day 2 of tirzepatide are really asking one of two things: "is this normal?" or "is it working?" The second cannot be answered on day 2. The headline trial figures describe results over 72 weeks, and individual results vary.²

02 · Your next steps

Is this normal, and what do you do next?

For most people, the right next step on day 2 is simply to look after yourself and wait. Do not judge the medicine on the scales or on how you feel today. Mounjaro is used alongside a reduced-calorie diet and increased physical activity, and the clinical effect builds across the dose ladder rather than from a single injection.²

Which of these situations sounds like you? If you feel fine or only mildly off, carry on and keep a short diary of symptoms for your monthly review. If you feel worse than expected, such as persistent vomiting or being unable to keep fluids down, contact your clinical team — dehydration needs medical help straight away.

If you want a closer look at what people commonly feel, our guide to day 2 side effects goes through them in more detail.

If you are still deciding whether to start, you can see current dose prices and begin a free consultation on the Mounjaro pen page. Your first 2.5mg pen costs £129.99 with code FIRST40 (standard price £169.99), and the consultation is reviewed by a GPhC-registered prescriber. Our weight loss clinic page explains the wider support available.

03 · Appetite and fullness

Appetite and fullness on day 2

Appetite change on day 2 is real for some people and absent for others, and both are normal. Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly, licensed in the UK for weight management in adults and for type 2 diabetes.¹ It comes as a pre-filled multi-dose KwikPen in six strengths, and everyone starts on the lowest, 2.5mg.

The mechanism explains what you might notice. Tirzepatide activates two natural gut-hormone receptors at once, GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties and improve the way the body responds to insulin.¹ In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet. That dual action is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide.

What does that look like in daily life? You might finish a plate sooner than usual, find that snacking urges are quieter, or notice that food you normally enjoy feels less appealing. Some people find the effect shows up in the evening rather than the morning. Others notice nothing until the dose is raised.

Because stomach emptying slows, fullness can also feel uncomfortable if you eat quickly or eat large portions. The practical rule is to eat smaller meals slowly and stop at the first feeling of fullness.

If your hunger seems unchanged, avoid the temptation to read that as failure. The starting dose exists to let your body adjust, and the licence is built around a gradual dose ladder. Pushing for a bigger effect on day 2 is not how the treatment is designed to work, and changing doses is a decision for your prescriber, never something to do yourself.

Equally, a strong early appetite drop is not a sign that you should eat as little as possible. Keep meals balanced and include protein, since your body still needs nourishment while appetite is quiet. If you are struggling to eat enough or feel unwell because of it, tell your clinical team.

A useful habit is to note, each evening, how hungry you felt between meals and how full you felt at the end of them. Brief notes like this make your monthly review far more useful than relying on memory, and the free GLPTrackr companion app is designed for tracking exactly this kind of GLP-1 journey detail. If you want more on lingering hunger, see our page on feeling hungry on day 2.

One more point of honesty: nobody can tell you precisely when your appetite will change. Variation between individuals is wide, and trial averages do not predict your own result.² What matters is the direction of travel across several weeks, reviewed with your prescriber, not a single quiet or noisy day.

04 · Nausea and digestion

Nausea, diarrhoea and other digestive effects

Digestive effects are the most common reason people feel off on day 2. Like all medicines, Mounjaro can cause side effects, and most are digestive. The most common — affecting more than 1 in 10 people — are nausea, diarrhoea, vomiting, constipation and abdominal discomfort.¹ Common effects (up to 1 in 10) include indigestion, reduced appetite, dizziness, reflux, burping, hair shedding and injection-site reactions.

In the trials supporting the weight-management licence, nausea and diarrhoea were reported far more often than on placebo, and they were more common while the dose was being increased and became less frequent over time.¹ That pattern matters for day 2: you are at the very start of the ladder on the lowest strength, so effects are typically at the milder end, though individual experience varies. Loose stools (diarrhoea) are one of the most common effects, and they usually ease as the body adjusts.

For most people these effects ease within days to a few weeks as the body adjusts.¹ Only a small minority stopped treatment permanently because of gastrointestinal side effects in the trials, which is reassuring if today feels rough.

Practical steps that help

• Eat smaller meals slowly and stop at the first feeling of fullness.
• Favour plain, lower-fat foods while you adjust.
• Stay well hydrated, sipping through the day.
• Avoid lying down straight after eating.

These steps help most people.¹ With diarrhoea in particular, fluids matter because you lose more than usual. With constipation, which is very common and may affect more than 1 in 10 people because food moves through the gut more slowly, fluid intake comes first, then fibre from vegetables and whole grains, then daily movement. If it persists, a pharmacist can recommend a suitable laxative, and you should contact your clinical team for pain, bloating or more than a few days without a bowel movement.

Bloating and burping are also part of the picture, because the stomach empties more slowly. Large, greasy or very rich meals tend to make this worse, so day 2 is a good time to keep food simple.

Know the threshold for getting help. If nausea or vomiting is persistent or you cannot keep fluids down, contact your clinical team — dehydration needs prompt attention. Do not try to push through severe symptoms. If a dose is hard to tolerate, prescribers can hold the current dose for longer before stepping up, which is one of the reasons treatment is supervised with ongoing reviews.

If you want a symptom-by-symptom walk-through, our page on Mounjaro side effects on day 2 covers the same ground with practical tips.

05 · Tiredness and other effects

Tiredness, dizziness and other early effects

Tiredness on day 2 is a recognised common side effect and usually fades within a few weeks. Fatigue is most noticeable in the first weeks and after dose increases. It usually reflects a mix of the body adjusting and simply eating less, so the response is to keep meals balanced, with protein especially, stay hydrated and keep gentle activity going.¹ For most people energy returns to normal within a few weeks. Tell your clinical team if tiredness is severe or not settling.

Dizziness is listed among the common effects. It is worth taking seriously in practical terms: stand up slowly, drink enough fluids and avoid driving or operating machinery if you feel unsteady. If dizziness is strong or comes with confusion, shakiness or sweating, and you take insulin or a sulfonylurea, watch for low blood sugar. Your prescriber may need to adjust those medicines, so tell them.¹

Injection-site reactions

Mild redness, itching, a small bruise or a tender lump at the injection site is common and normally settles within a few days. Rotating sites each week and letting the pen warm briefly out of the fridge reduces stinging. Contact your clinical team if a reaction is spreading, hot, very painful, or lasts more than a week.¹ In the weight-management trials, injection-site reactions were reported by 8.0% of people taking tirzepatide, compared with 1.8% on placebo.¹

Hair shedding

You will not notice hair changes on day 2, but it is worth knowing about. Temporary hair shedding is a recognised side effect, reported as common in trials and linked to rapid weight loss itself rather than a direct drug effect. For most people it settles as weight stabilises. Protein intake and overall nutrition matter, which is another reason the reduced-calorie diet should stay balanced.¹

Face and skin changes

Likewise, "Ozempic face" is not a drug effect. It is what losing a significant amount of weight quickly can do to facial volume, on any method including diet or surgery, and the same applies to loose skin. The counter-measures are the ones that protect lean mass: adequate protein, resistance exercise and a loss pace guided by your prescriber rather than maximum speed. Skin commonly adapts gradually after weight stabilises.¹

Day 2 is early for all of these, so treat them as background knowledge rather than things to worry about today. The full list of possible effects, including rarer ones, is in the patient information leaflet that comes with your pen.¹³ Tiredness, dizziness, hair loss and injection-site reactions are all on that list.

If you notice a symptom that is not on the leaflet list, it is not a listed side effect. Discuss any new symptom with your prescriber, and you can report suspected side effects through the MHRA Yellow Card scheme.¹⁹

06 · When to seek help

When to seek help: serious side effects

Serious side effects are uncommon, but they need urgent attention whatever day of treatment you are on. Seek immediate medical help for the following.¹

• Severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis).
• Pain in the upper right abdomen, fever or yellowing of skin or eyes (possible gallbladder problems).
• Signs of a severe allergic reaction, such as swelling of the face or throat and difficulty breathing. Get medical help straight away for swelling of the face or difficulty breathing.

It helps to understand the difference between ordinary discomfort and a warning sign. Ordinary early discomfort is usually mild to moderate, comes and goes with meals, and improves when you eat smaller portions or rest. A warning sign is severe, constant and does not ease, or comes with other symptoms such as fever or a change in skin colour. If you are unsure which you are experiencing, contact your clinical team or NHS services and describe exactly what you feel. For severe, constant pain, get medical help straight away. It is always better to ask.

Dehydration

Vomiting and diarrhoea together can leave you dehydrated quickly. If you cannot keep fluids down, contact your clinical team — dehydration needs medical help straight away.¹ Signs include a very dry mouth, dark urine, dizziness on standing and unusual weakness. Do not simply wait it out if these appear.

Low blood sugar with other medicines

If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar: shakiness, sweating and confusion. Your prescriber may need to adjust those medicines.¹ This is not a reason to stop your other medicines yourself, but it is a reason to tell your prescriber at the start, which our consultation process asks about.

Mood and wellbeing

Regulators have looked specifically at whether GLP-1 medicines are linked to low mood or suicidal thoughts. The EMA's safety committee reviewed the evidence and concluded in 2024 that it does not support a causal link, and the MHRA keeps this under continuous review.¹⁷ That said, any big change in weight, appetite and routine can affect how you feel. Tell your prescriber about any history of depression, and seek help promptly if your mood drops or you have distressing thoughts during treatment.

If you have thoughts of harming yourself or ending your life, get help straight away. Call 999 or go to A&E if you are in immediate danger. In England you can call NHS 111 and choose the mental health option, any time. You can also call Samaritans free on 116 123, day or night. Tell your prescriber about any change in your mood while taking Mounjaro.

Reporting side effects

If you think a symptom may be a side effect, you can report it through the MHRA Yellow Card scheme.¹⁹ Reports help regulators monitor safety, and you do not need to be certain the medicine caused the problem to make one.

At EverydayMeds, ongoing monthly reviews, dose titration and side-effect support are part of aftercare, and our support team can be reached Monday to Friday by email, account portal chat or phone. Out of those hours, or in an emergency, use NHS urgent services rather than waiting for us to reply.

07 · Early weight loss

Weight loss on day 2: what is realistic

Day 2 is too early to say anything meaningful about weight loss on Mounjaro. In SURMOUNT-1, people on tirzepatide lost on average 15% of body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone. These are trial averages. Individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.

Notice what that result describes: a long course, built up across the dose ladder. It says nothing about what happens over the first days. Any early change on the scales is likely to reflect day-to-day fluctuation, food and fluid intake, rather than a measured trend.

Can you lose weight on 2.5mg?

The 2.5mg pen is the starting strength. It is the first rung of a gradual dose ladder, which exists so that your body can adapt and side effects stay manageable. The headline SURMOUNT-1 results relate to the 5mg, 10mg and 15mg doses, not to the starter dose alone. Many people do notice appetite changes on the starting dose, but your prescriber, not the first week, decides how treatment progresses.

Signs it may be working

Instead of daily weigh-ins, look for steadier signals over several weeks: feeling full sooner, fewer cravings between meals, smaller portions feeling sufficient, and clothes fitting a little differently. Weight can fall without much change on some days, and shape can change before the scales do. Take measurements or photos at consistent intervals if that motivates you, and review progress at your monthly check-in rather than daily.

Comparing with other medicines

In the head-to-head SURMOUNT-5 trial, tirzepatide was compared directly with semaglutide in adults with obesity.¹⁵ It is the first large head-to-head trial, so results from separate trials should not be set side by side. If you are weighing options, our Wegovy pen page explains the alternative.

The honest summary: be patient, keep eating balanced meals with enough protein, stay active in ways you enjoy, and let the monthly review track progress. Treating day 2 as a pass-or-fail test will only make you anxious, and it is not a measure the evidence supports.

If you are concerned that nothing seems to be happening, our page on day 2 and no obvious effect goes through the most common reasons.

08 · The dose ladder

The dose ladder: what comes after day 2

Mounjaro uses a gradual ladder of doses, and day 2 sits at the very start of it. The pen comes in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹ Treatment begins at 2.5mg, and doses are stepped up after at least four weeks as tolerated, under your prescriber's guidance.

The ladder exists for a reason. Most side effects appear in the first days after starting or increasing a dose, peak early and settle as your body adapts. That is why the dose rises gradually rather than all at once.¹ Each time you step up, you may notice a brief return of effects like nausea or tiredness, much like the early days of treatment.

If a new dose is hard to tolerate, prescribers can hold the current dose longer before stepping up. Speak to your clinical team rather than pushing through severe symptoms.¹ Those are decisions that belong with your prescriber, and our reviews are there to make them safely.

For comparison: the Wegovy ladder

Wegovy, which contains semaglutide, uses its own ladder: 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg once weekly. It steps up after at least four weeks and reaches the 2.4mg maintenance dose from week 17.¹⁸ The two ladders look similar in shape but are different medicines with different strengths, so numbers are not interchangeable.

Stopping and clearing

Tirzepatide has a half-life of about five days, so after a final dose it takes roughly 4–5 weeks to clear the system — there is no way to speed this up, and nothing needs doing while it clears.¹ It also means that a rough day 2 does not disappear instantly if you decide to stop, so speak to your prescriber if you are thinking of doing so.

Your injection day

Because Mounjaro is a once-weekly injection, your chosen weekday matters. If you miss a dose, take it as soon as you can within 4 days (96 hours) of the scheduled time; if more than 4 days have passed, skip the missed dose and take the next one on your normal day — never take two doses within 3 days of each other. Our page on taking Mounjaro a day later goes through the practical question. Looking ahead, the end of the first week is covered in our guide to day 7 on Mounjaro.

Your first order is the beginning of an ongoing process. At EverydayMeds, repeat orders re-check suitability and nothing auto-ships, so each step on the ladder is a deliberate, reviewed decision.

09 · Injection and storage

Injection, site care and storing your pen

Looking after the injection site and the pen makes the early days smoother. Mild redness, itching, a small bruise or a tender lump at the site is common and normally settles within a few days. Rotating sites each week and letting the pen warm briefly out of the fridge reduces stinging.¹ Contact your clinical team if a reaction is spreading, hot, very painful or lasts more than a week.

Follow the pen's instructions for the injection itself. The instructions that come with your pen are the authority, and the patient information leaflet shows each step.¹³ Needles, a sharps bin and injection guidance are included with every order, so you are not left working it out alone.

Storing the pen

Unopened pens belong in the fridge, at 2–8°C, until first use, and they keep until the printed expiry date.¹³ Once in use, a pen can be kept out of the fridge at a temperature not above 30°C for up to 30 days after first use, and must then be thrown away. Do not use a pen that has been above 30°C or frozen.¹ If you have a question about an unopened pen that has been out of the fridge, check the patient information leaflet and contact the pharmacy rather than guessing. Do not use a pen if you are unsure it has been stored correctly, since sterility and potency are no longer assured outside the tested window.

Delivery and cold chain

Pens arrive by free next-day tracked delivery in temperature-controlled, discreet packaging, with same-day dispatch when ordered by 3pm. Saturday delivery costs £14.99. When your parcel arrives, open it promptly and put the pens in the fridge. If the package looks damaged or something is missing, contact us; faulty, damaged or wrong items must be reported within the stated window.

Genuine pens matter

The pens you inject should be genuine, dispensed against a prescription. Our supply comes through official LillyDirect channels, directly from Eli Lilly's UK distribution, and we are registered with the General Pharmaceutical Council (GPhC 9012878). Be wary of anyone offering to supply without a consultation or prescription, and report suspect products through the MHRA Yellow Card scheme.¹⁹

A final practical tip for day 2: if you are anxious about the next injection, read through the leaflet again calmly before your next scheduled day, and make a note of any questions for your clinical team. Those questions are exactly what monthly reviews are for.

10 · NHS and private options

NHS and private access to Mounjaro

If you are on day 2 of tirzepatide privately, or considering it, it helps to understand the NHS picture. Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

You can read the NHS's own overview of the medicine on its tirzepatide page.⁵ Whichever route you take, treatment is used alongside a reduced-calorie diet and increased physical activity, and individual results vary. This page is information, not a substitute for medical advice.

How private treatment works with us

Mounjaro is prescription-only and supplied only after an online consultation reviewed by a GPhC-registered prescriber. Our process has four steps.

• Free online consultation: a short health questionnaire, with no charge and no obligation.
• Prescriber review: reviewed by a GPhC-registered prescriber, not a scoring script. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.
• Dispensing and dispatch: dispensed by our registered pharmacy, with same-day dispatch when ordered by 3pm.
• Delivery: free next-day tracked delivery in temperature-controlled, discreet packaging.

The consultation is free, the price shown is the price paid, and there are no hidden fees. You can pay by Visa or Mastercard, with Klarna or with pay-monthly options, and there are no subscriptions.

What it costs, in outline

Each pen lasts four weeks. Your first 2.5mg pen costs £129.99 with code FIRST40 (standard price £169.99), and a new-customer discount applies to a first order at any dose. After that, every later order is £25 off the standard price through an automatic reorder discount (code DOSE25). If you step up after 4 weeks on each dose, your first four pens (2.5mg to 10mg) cost £959.96 at standard prices, before discounts. A first year costs £2,711.88 if you stay on 5mg after your 2.5mg starting pen, up to £3,599.88 if you step up through every dose to 15mg, again before discounts. Prices were checked 10 October 2026, and all six doses are in stock.

You can see current prices and start a free consultation on the Mounjaro pen page. If you are interested in stocking up, our page on buying several pens explains how ordering works, though each repeat order re-checks suitability.

Support afterwards includes ongoing monthly reviews, dose-titration and follow-up assessments by the prescribing team, plus side-effect support and the free GLPTrackr companion app. That support is what you lean on if day 2, or any later day, does not go quite as expected.